Onesource Specialty Pharma Ltd. (ONESOURCE)の価格はいくらですか

Onesource Specialty Pharma Ltd. (ONESOURCE)の価格は$16.75です

Onesource Specialty Pharma Ltd. (ONESOURCE)の時価総額は何ですか

Onesource Specialty Pharma Ltd. (ONESOURCE)の時価総額は$1.92Bです

Onesource Specialty Pharma Ltd.（ONESOURCE）株式分割

OneSource Specialty Pharma Limited is a biopharmaceutical company focused on the discovery, advancement, production, and market introduction of biological drug products, primarily offered in diverse injectable formulations. The company conducts its operations internationally, with a footprint in India, Ireland, and the United States. It delivers comprehensive contract development and manufacturing (CDMO) services for biologics, encompassing all phases from preclinical and clinical development to commercial-scale supply. Its offerings extend to integrated drug-device systems such as pre-filled syringes, various pen injectors (including dial, push, and pull-push types for both variable and fixed doses), and autoinjectors. Furthermore, OneSource Specialty Pharma manufactures sterile injectable drugs and soft gelatin capsules, and provides specialized biologics solutions tailored for microbial and mammalian cell-line biopharmaceuticals, as well as for cell, gene, and RNA therapies. Established in 2007, the company, headquartered in Bengaluru, India, was formerly known as Stelis Biopharma Limited until its rebranding in February 2024.